Wells Fargo’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4K Sell
19,577
-500
-2% -$341 ﹤0.01% 5431
2025
Q1
$18.3K Hold
20,077
﹤0.01% 5280
2024
Q4
$21.9K Hold
20,077
﹤0.01% 5246
2024
Q3
$15.2K Sell
20,077
-606
-3% -$459 ﹤0.01% 5300
2024
Q2
$25.6K Sell
20,683
-10,205
-33% -$12.7K ﹤0.01% 5143
2024
Q1
$58.4K Buy
30,888
+1,466
+5% +$2.77K ﹤0.01% 4812
2023
Q4
$77.7K Sell
29,422
-48,762
-62% -$129K ﹤0.01% 4650
2023
Q3
$180K Buy
78,184
+8,624
+12% +$19.8K ﹤0.01% 4115
2023
Q2
$254K Buy
69,560
+18,234
+36% +$66.6K ﹤0.01% 4200
2023
Q1
$183K Buy
51,326
+3,205
+7% +$11.4K ﹤0.01% 4218
2022
Q4
$137K Buy
48,121
+28,111
+140% +$80.1K ﹤0.01% 4099
2022
Q3
$45K Buy
20,010
+20
+0.1% +$45 ﹤0.01% 4701
2022
Q2
$50K Buy
19,990
+11,289
+130% +$28.2K ﹤0.01% 4742
2022
Q1
$43K Sell
8,701
-8,946
-51% -$44.2K ﹤0.01% 5392
2021
Q4
$200K Buy
17,647
+16,647
+1,665% +$189K ﹤0.01% 4901
2021
Q3
$15K Hold
1,000
﹤0.01% 5736
2021
Q2
$12K Sell
1,000
-6,341
-86% -$76.1K ﹤0.01% 5745
2021
Q1
$89K Sell
7,341
-45,276
-86% -$549K ﹤0.01% 5189
2020
Q4
$658K Sell
52,617
-164
-0.3% -$2.05K ﹤0.01% 4252
2020
Q3
$795K Sell
52,781
-2,984
-5% -$44.9K ﹤0.01% 3936
2020
Q2
$1.37M Buy
55,765
+17,903
+47% +$439K ﹤0.01% 3501
2020
Q1
$537K Buy
37,862
+6,596
+21% +$93.6K ﹤0.01% 3865
2019
Q4
$496K Buy
31,266
+4,321
+16% +$68.5K ﹤0.01% 4275
2019
Q3
$227K Sell
26,945
-202
-0.7% -$1.7K ﹤0.01% 4712
2019
Q2
$244K Sell
27,147
-7,208
-21% -$64.8K ﹤0.01% 4690
2019
Q1
$266K Sell
34,355
-2,055
-6% -$15.9K ﹤0.01% 4610
2018
Q4
$171K Buy
36,410
+16,480
+83% +$77.4K ﹤0.01% 4814
2018
Q3
$181K Buy
19,930
+444
+2% +$4.03K ﹤0.01% 4872
2018
Q2
$231K Buy
19,486
+14,392
+283% +$171K ﹤0.01% 4791
2018
Q1
$72K Buy
+5,094
New +$72K ﹤0.01% 5176